MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sorensen, R. G.
Right arrow Articles by Blaustein, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sorensen, R. G.
Right arrow Articles by Blaustein, M. P.

Rat brain dendrotoxin receptors associated with voltage-gated potassium channels: dendrotoxin binding and receptor solubilization

RG Sorensen and MP Blaustein

Department of Physiology, University of Maryland School of Medicine, Baltimore 21201.

Venom from the green mamba, Dendroaspis angusticeps, contains four polypeptides termed dendrotoxins (DaTXs) that block brain Ca- independent voltage-gated K channels. We compared the binding to rat brain receptors of two of these DTXs, alpha-DaTX and beta-DaTX, which preferentially block inactivating and noninactivating K channels, respectively. 125I-alpha-DaTX and 125I-beta-DaTX bind to single classes of receptor sites on synaptic membranes (KD = 0.7 and 36 nM for alpha- DaTX and beta-DaTX, respectively), with pH optima of about 6.5. The binding of both iodinated toxins was optimal in solutions containing 150 mM NaCl and decreased as Na was replaced with other alkali metal ions; the rank order for support of toxin binding was Na greater than K greater than Li greater than Rb. Cs (IC50 = 5-6 mM) prevented toxin binding, as did the divalent cations Ba and Ca (IC50 = 4-6 and 9-13 mM, respectively). The inhibition of 125I-alpha-DaTX binding by Cs and Ba was noncompetitive. The displacement of 125I-alpha-DaTX and 125I-beta- DaTX binding by the four unlabeled DaTXs was similar; the relative potency was alpha-DaTX greater than beta-DaTX greater than gamma-DaTX. The displacement curve for delta-DaTX did not parallel the others. When cross-linked with dimethylsuberimidate, both iodinated toxins covalently labeled membrane polypeptides of similar molecular weight (Mr = 65,000). The alpha-DaTX and beta-DaTX receptors were solubilized from rat synaptic membranes. Toxin binding to the soluble from rat synaptic membranes. Toxin binding to the soluble receptors was preserved in the presence of K and lecithin and decreased as K was replaced with Rb greater than Cs greater than Li greater than Na. The affinity of 125I-alpha-DaTX for the solubilized receptor was decreased 10-fold (KD = 7 nM); the affinity of 125I-beta-DaTX was decreased 3.5- fold (KD = 124 nM). However, the four unlabeled DaTXs retained their relative potencies for the inhibition of 125I-alpha-DaTX binding. The molecular weight of the solubilized receptor was estimated to be about 270,000 by sucrose density gradient centrifugation. These data raise the possibility that the inactivating ("A-type") and noninactivating voltage-gated K channels in rat brain may have similar subunits and that the channels may be composed of four Mr 65,000 polypeptides.

Volume 36, Issue 5, pp. 689-698, 11/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
J. Scuvee-Moreau, J.-F. Liegeois, L. Massotte, and V. Seutin
Methyl-Laudanosine: A New Pharmacological Tool to Investigate the Function of Small-Conductance Ca2+-Activated K+ Channels
J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 1176 - 1183.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1989 by the American Society for Pharmacology and Experimental Therapeutics